Ascendant Dx, an Arkansas-based biotech company, develops and commercializes high-value proteomics-based diagnostic tests. The firm focuses on areas of diagnostics where conclusive diagnostic tests are not yet available. Ascendant's tests combine the latest discoveries in proteomics with proven diagnostic platforms, aiming for tests that are simpler, more accurate and widely available. Ascendant Dx, LLC is a VIC Technology Venture Development™ portfolio company.
| Date | Amount | Type | Investors | Valuation |
|---|---|---|---|---|
| 05/20/14 | $2,000,000 |
Arkansas Development Finance Authority Arkansas Science and Technology Administration | undisclosed |
